PDS Biotechnology (PDSB) Tops Q3 EPS by 2c

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
• Ciena beats estimates on strong AI-driven demand, shares rise
• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance